Acyclovir sodium and Fentanyl citrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir sodium (acyclovir sodium) and Fentanyl citrate (fentanyl citrate). Common drug interactions include necrosis among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Acyclovir sodium and Fentanyl citrate. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Acyclovir sodium?

Acyclovir sodium has active ingredients of acyclovir sodium. eHealthMe is studying from 1,813 Acyclovir sodium users. Check the latest studies of Acyclovir sodium.

What is Fentanyl citrate?

Fentanyl citrate has active ingredients of fentanyl citrate. It is often used in pain. eHealthMe is studying from 21,294 Fentanyl citrate users. Check the latest studies of Fentanyl citrate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

14 people who take Acyclovir sodium and Fentanyl citrate together, and have interactions are studied.

Acyclovir sodium and Fentanyl citrate drug interactions.

What are the common drug interactions of Acyclovir Sodium and Fentanyl Citrate, by gender? *:

female:

  1. Necrosis (the death of body tissue)
  2. Pain in extremity
  3. Anaemia (lack of blood)
  4. Histiocytosis haematophagic
  5. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  6. Apnoeic attack
  7. Arrhythmia (irregular heartbeat)
  8. Blood pressure increased
  9. Body temperature increased
  10. Chills (felling of cold)

male:

  1. Cardiac failure congestive
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Discomfort
  4. Emotional distress
  5. Hypophagia (reduced food intake)
  6. Injury
  7. Myelitis transverse (a neurological condition consisting of an inflammatory process of the spinal cord)
  8. Osteonecrosis of jaw (death of bone of jaw)
  9. Pleural fibrosis (formation of fibrous tissue in lung)
  10. Pneumonitis (inflammation of the walls of the alveoli in the lungs)

What are the common drug interactions of Acyclovir Sodium and Fentanyl Citrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Anaemia (lack of blood)
  2. Circulatory collapse
  3. Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus)
  4. Haemorrhage (bleeding)
  5. Histiocytosis haematophagic
  6. Hyperammonaemia
  7. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  8. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  9. Infection
  10. Oedema (fluid collection in tissue)

10-19:

n/a

20-29:

  1. Abdominal pain upper
  2. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Constipation
  5. Hepatic enzyme increased
  6. Histiocytosis haematophagic
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Rash
  9. Serum ferritin increased
  10. Varicella virus test positive

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Atrophic vulvovaginitis (inflammation of the vulva)
  5. Back pain
  6. Bone disorder
  7. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  8. Bone pain
  9. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

50-59:

  1. Cardiac failure congestive
  2. Cauda equina syndrome (affecting the bundle of nerve roots)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Chronic respiratory failure
  6. Constipation
  7. Decreased appetite
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Drug dependence
  10. Drug hypersensitivity

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. General physical health deterioration (weak health status)
  3. Bone pain
  4. Chest pain
  5. Chills (felling of cold)
  6. Creatinine renal clearance decreased
  7. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  8. Dehydration (dryness resulting from the removal of water)
  9. Discomfort
  10. Dysphagia (a condition in which swallowing is difficult or painful)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 6 people, 42.86%
  2. Urinary Tract Infection: 1 person, 7.14%
  3. High Blood Cholesterol: 1 person, 7.14%
  4. Bone Marrow Conditioning Regimen: 1 person, 7.14%
  5. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.14%
  6. Circulatory Collapse: 1 person, 7.14%
  7. Constipation: 1 person, 7.14%
  8. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 7.14%
  9. Depression: 1 person, 7.14%
  10. Face Oedema (swelling of face): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir sodium and Fentanyl citrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acyclovir sodium and Fentanyl citrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acyclovir sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fentanyl citrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fentanyl citrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acyclovir sodium and fentanyl citrate (the active ingredients of Acyclovir sodium and Fentanyl citrate, respectively), and Acyclovir sodium and Fentanyl citrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: